New Delhi, March 19, 2026 – J Mitra & Company, India’s pioneer in the in-vitro diagnostics (IVD) industry, has been honoured with the prestigious ‘Best BioTech Company of the Year’ award at the FE Pharma Summit & Awards 2026. The ceremony, held today in New Delhi, brought together the nation’s top pharmaceutical leaders, policymakers, and healthcare innovators to celebrate excellence in the life sciences sector.
The award recognises J Mitra & Company’s nearly six decades of leadership and its relentless pursuit of indigenous innovation. Known for transforming the Indian diagnostic landscape, the company was lauded for its robust Research & Development (R&D) ecosystem, which has consistently delivered high-quality, affordable, and accessible diagnostic solutions.
With over 65 patents, the highest for any company in its segment in India, J Mitra continues to lead the “Make in India” initiative for the global stage. The company’s R&D department is at the heart of its operations, focusing on “frugal medical engineering” to ensure that advanced medical technology reaches the remotest parts of the country and the world.
Speaking on the achievement, Mr Jatin Mahajan, Managing Director of J Mitra & Company, said, “This recognition as the Best BioTech Company of the Year is a testament to our team’s dedication to scientific excellence. At J Mitra, R&D is not just a department; it is our foundation. We remain committed to pushing the boundaries of biotechnology to create solutions that are not only world-class in accuracy but also tailored to the unique challenges of the Indian healthcare ecosystem.”
About J Mitra & Company
Established in 1969, J Mitra & Co. is a research-based biotechnology leader and the largest exporter of diagnostic kits from India, serving over 45 countries. The company’s extensive portfolio includes rapid tests. ELISA kits and CLIA test kits for infectious diseases such as HIV, HBV, HCV, Dengue, and Malaria. By bridging the gap between advanced technology and affordability, J Mitra continues to serve its mission of preserving human lives through innovation.
